Nicole Vitullo joined Domain Associates, L.L.C. in 1999 and became a Partner in 2004. She has full management responsibility for Domain Public Equity Partners, L.P. and is also involved in distribution/liquidation strategies for the public companies in Domain Associate’s venture capital portfolios. Present board memberships include Celator Pharmaceuticals, Inc.; Cerexa, Inc.; Ruxton Pharmaceuticals; and Marinus Pharmaceuticals. Past Board memberships include Onyx Pharmaceuticals and Eunoe, Inc. From 1992-1999, Ms. Vitullo was Senior Vice President at Rothschild Asset Management, Inc. where she had responsibility for the U.S. public market investments of International Biotechnology Trust plc and Biotechnology Investments Limited. From 1991-1992, Ms. Vitullo served as the Director of Corporation Communications and Investor Relations at Cephalon, a publicly traded biotechnology company. Prior to Cephalon, Ms. Vitullo spent 12 years at Eastman Kodak, most recently in Corporation Development where she was involved in the development management of Kodak’s venture capital activities. Ms. Vitullo has a B.A. and an M.B.A. from the University of Rochester.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Marinus Pharmaceuticals | Board of Directors | — | — | Detail |